ENTITY

Dicerna Pharmaceuticals (DRNA US)

Analysis

Health Care • United States

Dicerna Pharmaceuticals, Inc. provides biopharmaceutical products. The Company discovers and develops ribonucleic acid for the treatment of liver diseases and cancer.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00